GlobalData

While the most effective vaccines will ramp up production to meet global demand, the opportunity for less effective vaccines will…

Social media and cloud computing became the most dominant technologies for current investments for pharma in 2020

Late-stage clinical trials of intranasal COVID-19 vaccines are expected to begin in India in the coming months

Three major deals contributes 72 per cent of total deal value

The success of digital transformation will heavily depend on employees being on board and adapting as digital transformation…

The SOLIDARITY trial did show that large-scale international trials are possible during a pandemic with the possibility of drawing…

The COVID-19 halo effect is driving extra funding to many small pharma companies, especially those in the infectious disease space

Many new therapies entering the market have different mechanisms of action (MOA) and are aiming to meet needs in different…

Unlike convalescent plasma, hIVIG is a plasma product that is a standardised and concentrated mixture of polyclonal antibodies…

Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael…